Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCENT: Aplaviroc + Combivir in HIV-1
NCT00104429Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- Jan 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of aplaviroc in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Jan 2005; status: terminated.
02
Drugs
aplaviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00104429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104429.